Email Editor Eisai Co. Ltd. (T: 4523), through its American subsidiary, is acquiring four oncology-related products from Ligand for $205.0 million, or 3.87x revenue. The products include ONTAK, Targretin capsules, Targretin gel 1% and Panretin gel 1%. Eisai’s goals in...
Email Editor Based on preliminary figures, a total of 237 mergers and acquisitions were announced in the health care industry during the third quarter of 2006. The nine sectors of the health care services segment accounted for 136 deals, or 57% of the quarter’s total...
Three Family-Owned European Drug Firms Sell In One Week Email Editor Dealmaking in the Pharmaceuticals sector, as well as reporting on it, has often focused on two extremes: the merger of mega-pharma conglomerates at one end and the consolidation of generic pharma...
Email Editor The month of August saw a total of 68 mergers and acquisitions announced in 13 sectors of the health care industry. The month’s deal volume dropped ever so slightly from July’s tally of 69 deals. The nine sectors of the health care services segment...
Email Editor Over the past year, we have covered deals in which Indian pharmaceutical companies stretched their wings and made acquisitions in Europe and the United States. With the dismantling of the “Permit Raj”—a hornet’s nest of bureaucracy and...
July Sees 69 Deals Worth A Combined $35.5 Billion Email Editor The month of July saw a total of 69 mergers and acquisitions announced in 13 sectors of the health care industry, down 17% from the 81 deals announced in June. The nine sectors of the services segment...